478
Participants
Start Date
August 26, 2013
Primary Completion Date
August 6, 2016
Study Completion Date
November 10, 2016
Gadobutrol (Gadavist, Gadovist, BAY86-4875)
Participants received gadobutrol at the total approved standard dose of 0.1 millimole per kilogram body weight (mmol/kg BW) in 2 separate bolus injections: 0.05 mmol/kg BW at peak pharmacologic stress and 0.05 mmol/kg BW at rest via a power injector.
Chermside
North Adelaide
Adelaide
Perth
Philadelphia
Bethesda
Bethesda
Charlottesville
Durham
Charleston
Atlanta
Columbus
Cleveland
St Louis
Houston
Tucson
Singapore
Los Angeles
Chicago
Boston
London
Montreal
Montreal
Singapore
Lead Sponsor
Bayer
INDUSTRY